Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care

Compared to standard of care, patients with schizophrenia treated with aripiprazole experienced decreased weight and improved weight-related quality of life over 26 weeks. These changes were both statistically and clinically significant.